logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8969325 B1

PDFFull Text
Date of Patent:
Mar. 03, 2015

Filed:

Dec. 17, 2012

Trpv1 antagonists

Applicant:

Abbvie Inc., North Chicago, IL (US);

Inventors:

Michael J. Dart, Highland Park, IL (US);

Philip R. Kym, Libertyville, IL (US);

Eric A. Voight, Pleasant Prarie, WI (US);

Anurupa Shrestha, Gurnee, IL (US);

Jerome F. Daanen, Racine, WI (US);

Tammie K. Jinkerson, Pleasant Prairie, WI (US);

Ryan G. Keddy, Beach Park, IL (US);

Sridhar Peddi, Schaumburg, IL (US);

Arthur Gomtsyan, Vernon Hills, IL (US);

Michael E. Kort, Lake Bluff, IL (US);

Gregory A. Gfesser, Lindenhurst, IL (US);

Kevin R. Woller, Antioch, IL (US);

Derek W. Nelson, Highland Park, IL (US);

Assignee:

AbbVie Inc., North Chicago, IL (US);

Attorney:
Primary Examiner:

James D Anderson

Int. Cl.
CPC ...
C07D 405/12 (2006.01); C07D 215/38 (2006.01); C07D 239/80 (2006.01); C07D 413/12 (2006.01); C07D 491/052 (2006.01); A61K 31/192 (2006.01); A61K 31/4704 (2006.01); A61K 31/4709 (2006.01); A61K 31/517 (2006.01); A61K 31/538 (2006.01); A61K 45/06 (2006.01); C07D 413/14 (2006.01); C07D 215/227 (2006.01); C07D 265/36 (2006.01);
U.S. Cl.
CPC ...
C07D 405/12 (2013.01); C07D 413/14 (2013.01); C07D 215/227 (2013.01); C07D 239/80 (2013.01); C07D 413/12 (2013.01); C07D 491/052 (2013.01); C07D 265/36 (2013.01); A61K 31/192 (2013.01); A61K 31/4704 (2013.01); A61K 31/4709 (2013.01); A61K 31/517 (2013.01); A61K 31/538 (2013.01); A61K 45/06 (2013.01); C07D 215/38 (2013.01);
Abstract

Disclosed herein are compounds of formula (I): or pharmaceutically acceptable salts thereof, wherein X, L, R, R, G, Z, A, m, n, and p are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

Find Patent Forward Citations

Loading…